{
    "2020-03-26": [
        [
            {
                "time": "",
                "original_text": "华东医药：大股东从未二级市场减持，续质押股份是正常融资行为，减持股份",
                "features": {
                    "keywords": [
                        "华东医药",
                        "大股东",
                        "减持",
                        "质押",
                        "融资"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "带量采购推行下，医药代表还有路可走吗？",
                "features": {
                    "keywords": [
                        "带量采购",
                        "医药代表",
                        "政策影响"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}